"Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival or QoL w/in 5 yrs of accelerated approval. Patients should be clearly informed about the cancer drugs that use the accelerated approval pathway (...)" from http
So far, Altmetric has seen
755 X posts from 644 X users, with an upper bound of 3,312,016 followers.
601 followers
337 followers
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval | Oncology | JAMA | JAMA Network https://t.co/Pmk4ddBO17
75 followers
Faster is not always better #cancer #drugs https://t.co/sSxiOisyr0
551 followers
RT @JAMA_current: Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival or quality of life within…